Updates from the Health Technology Assessment Policy and Methods Review Reference Committee (June 2023)

9 June 2023 - The following documents are now available: ...

Read more →

May 2023 updates from the Health Technology Assessment Policy and Methods Review Reference Committee

11 May 2023 - Information regarding the experts in HTA to support the HTA Review is now available. ...

Read more →

Rebuilding Medicare for the 21st century

28 April 2023 - The Australian Government is laying the foundations for significant reforms to Medicare, with a comprehensive package of ...

Read more →

Sales agent change gives red light to Gavreto’s reimbursement review

26 April 2023 - The changes in sales right for Gavreto (pralsetinib), an RET inhibitor, may likely negatively influence the ...

Read more →

Updates from the Health Technology Assessment Policy and Methods Review Reference Committee – March and April 2023

20 April 2023 - The Health Technology Assessment Policy and Methods Review Reference Committee met on 24 March 2023 and ...

Read more →

HTA reform starts today – consultations open

11 April 2023 - Medicines Australia welcomes the official start of the Health Technology Assessment (HTA) Review consultation that should ...

Read more →

Health technology assessment policy and methods review consultation

11 April 2023 - The first round of public consultation for the HTA Review is open. Submissions will be accepted ...

Read more →

Medicare system is ‘not fit for purpose’, review finds

4 April 2023 - Australia’s health funding system is “fragmented and disjointed” and in critical need of being simplified, says ...

Read more →

HTA reform gets underway – terms of reference released today

22 March 2023 - Medicines Australia acknowledges the Health Technology Assessment Review Terms of Reference – released today – and ...

Read more →

Terms of reference for the Health Technology Assessment Policy and Methods Review

22 March 2023 - The terms of reference for the Health Technology Assessment Policy and Methods Review is now available. ...

Read more →

CEO’s appointment to HTA Review Reference Committee

15 March 2023 - CEO of Medicines Australia, Elizabeth de Somer, has been appointed as the medicines industry representative on ...

Read more →

Updates from the Health Technology Assessment Policy and Methods Review Reference Committee (March 2023)

9 March 2023 - The Health Technology Assessment Policy and Methods Review Reference Committee met on 13 February 2023.  ...

Read more →

PHARMAC releases final response to review

3 March 2023 - "There are 30 actions we committed to in the interim response – these are part of ...

Read more →

“Killing time” one year on, still no final response from PHARMAC to the independent review

28 February 2023 - Today marks one year since the PHARMAC Review was delivered to then Health Minister Andrew Little. ...

Read more →

ABPI response to Lord O'Shaughnessy review

20 February 2023 - The Office for Life Sciences has today announced that Lord James O’Shaughnessy will conduct a review ...

Read more →